Member Info for BOJO2020

Let’s see if the finance comes through within stated time frame (next 7 days). It would certainly be nice as I hold a chunk of these now, but you can’t trust anybody with your money can you. If there is a delay I would buy more but it’s surely not the time to add as a spike is coming either way.

I agree Mia,

Research notes and studies may move the SP in the first instance but having 10x that number certainly should not lead to SP x10.

I think we have an embarrassment of riches in terms of peer reviewed studies and that gives me conviction that my money is in the right place.

Clearly there are things that can effect the SP such as heavy buying etc but those of very short term phenomena. I guess what is driving that kind of buying is a more interesting question.

Great news won’t be long now!

To be fair I didn’t know anything about the article until Dalester pointed it out. I simply posted the link afterward as I thought it might be helpful.

My opinion, wonderful to see we have competition for a variant proof covid vax. It will add choice and substance, can’t be a bad thing IMO.

The latest I hear from the BBC is that there is now a Llama COVID vaccine doing the rounds! Marvellous and good luck to the scientists that have worked out that Llamas, camels and sharks have a biology that is less complicated and potentially therefore more effective at dealing with infections than we humans. Anyway, the mice seem to like the vax which is being delivered by nasal spray. Trials in humans are up and coming.

Why these people are even entertained. Clearly this is an excellent bb but it will not remain so if we interact with posters that are clearly being disruptive and antagonistic. They lack structure hunger. If we ignore then they will go away and cause trouble elsewhere.

https://www.telegraph.co.uk/news/2021/09/20/first-variant-proof-covid-vaccine-starts-trials-manchester/

Correct, I have just checked Angle website and only one RNS.

that we will get FDA approval this week. Can’t tell you why as obviously it’s a complete guess! If I am pushed I would say Thursday.

Good Luck All

Yes crumbs I see that registering a trail means only that. The trial itself would need to be conducted of course. That is an important point you mention as who is to say that some registered, would ever make it to trial. Therefore certainly not SP sensitive IMO.

So we have registered the trial in the US. Is that with a view to using the trail data from SA and UK. Or, is this another arm of the COVIDITY study actually in the US?

Thanks in advance.

https://clinicaltrials.gov/ct2/show/NCT05047445

So by clicking on the link you will find details of trial registered for COVIDITY. By clicking on the Next Trial tab you will also see SCIBI 1 trial. So that’s two separate trials registered on Friday.

This of course does not mean anything in particular in terms of data but it does mean news flow is expected. Obviously timelines should be heeded but it’s worth bearing in mind the institutional support so I doubt the SP will drop unless the market in general gets spooked.

ATB

Jake York,

I suspect that you would like to buy Angle shares at a discount?? Have you tried Woucher? Maybe you could get a discount code from google possibly?

Do let us all know how you get on BTW.

Forgive me if I am misreading your intentions but I think not!

ATB.

Maybe this cancellation will allow the UK Gov to buy COVIDITY VAX from Scancell!

Joking of course as that Vax has not passed trials yet.

I was sat in the sidelines feeling sorry for myself. The market gods in their infinite wisdom kindly dropped the price so I could get on board. It literally was like running to the train station to find I actually had time to spare. I have chosen a cosy seat by the window. Just time for a quick nap as I am safe in the knowledge I have a ton of these golden tickets.

Wake me up at 50p if you don’t mind!

Nolupus,

Looks like Trev has found his Angle after all…;-)

ATB

Phantom25,

Thanks for your reply.

I think the question of how many Parsortix systems the NHS may require is fanciful to be honest. I certainly find it an interesting question, but its not one that is likely to become relevant until years to come. (in terms of my investment at least).

It does no harm to calculate the number of systems and cartridges required and a formulaic calculation may be very interesting for future general hypothesis, but if someone were to say that would lead to a £20 billion order from the NHS and they thought that it would happen by XX date, then it becomes ridiculous, dont you think? Unless of course it were delivered by RNS!

My logic is, concentrate on the now and near term future. Keep an eye on where the Company intends to go in the long term by all means but the closer we look to the present, the more realistic is the proposition. I would add, that AN and the BOD long term planning is not only exciting but well considered and thorough. Very credible IMO. I happen to trust the long term ambitions and I have a feeling that aside from the NHS connections you have pointed out, we have many more irons in the fire with the NHS and other large organizations.

Time and timing plays a large in my thinking so as always, patience required. That's just the way I do things and I hope it doesn't come across as preaching. Each to their own ways of course.

ATB

I am sure AN would welcome collaborative studies with the NHS. It would be another plate to spin and that would only prove mutually beneficial.

Personally I do not expect the NHS to be jumping on board with both feet and waving the flag for Angle just so we can feel excited and cash in our shares…It will (and maybe already has) involve a lot of hard work and relationship building. Not to mention indisputable scientific evidence that shows Parsortix is a key component in fighting a broad range of cancers.

That said, if an oncologist or particular relevant person in the NHS feels they need Parsortix, I am sure they would make the case and get one.

Basically this ain’t ready for such a big step. Patience required for this one.

A sensible and common strategy is to sell some just before news and then buy back in once completely derisked. I would suggest however that it would only apply if you had doubled or trebled your original stake… clearly as that has not happened here in most cases, (daytraders senario explained above) unless you were selling some from 4p or less. It would make sense to some investors to sell a few and bank some profit.

I actually think it is naive to suggest that people should not be selling at this point! In the right circumstances it makes perfect sense.

My own circumstances are I have an 8p average so I will be holding for a considerable time and expect to make a very tidy sum.

ATB.

You could do worse than to sign up for email notifications with from NEXT SOURCE MATERIALS. They sat around like us for many years on the giant molo graphite mine until Vision Blue came along 6 months ago. Now it is all happening for them and we are only a step or two behind IMO.

It goes without saying that without finance nothing much will happen, or so it may appear…however it became clear that there was keen “pent up” demand for molo graphite and when the potential of Next was unleashed on to the EV market, companies were beating down the door to get their hands on it and coming back for more. Wouldn’t that suit us very nicely with a further 75% asset potential here!

This is a half pump of Next on my part but as I see it we are filling in their footsteps.

I think our bod have a lot of things lined up for us here and when finance is arranged/announced we shall see all the hard work the company has put into making us mucho ££$$€€.

https://www.accesswire.com/663051/NextSource-Materials-to-Explore-Additional-Strategic-Asset-Opportunities-in-Clean-Energy-Materials

This is just a flavour of the excitement at Next that is heading our way soon.

ATB

Thanks for the replies.

I think you have it about right ihowells. If it gets the right momentum then 40 to 45p is possible for a day spike. Surely 16 to 20p would be base camp.

John, also sold out if ARCM. Holding HZM, ACP and Next Source tight. Still have not sold any SAV. The CEO, asset and setup reminds me of Ferro Alloy before Vision Blue stepped in… Nick Bridgeon is proof that nice guys don’t always finish last.

I am now crying BTW that I did not buy REDX despite having to clear opportunities lol.

Good Luck All

Starting to look like a good call from you ihowells! I have not sold a share yet.

What is your view currently I wonder? If finance is approved, any idea on SP?